explore -WSS

explore

author：entertainment 2025-09-29 18:17:25 - browse：15793

insulin biosimilar — The suit, filed in a Texas federal court by the American Clinical Laboratory Association and PCR lab HealthTrackRx, claims the FDA does not have the authority to scrutinize lab-developed tests. Jacquelyn Martin/AP

A group representing clinical labs across the country sued the Food and Drug Administration on Wednesday over the agency’s plan to actively regulate lab-developed tests.

The suit, filed in a Texas federal court by the American Clinical Laboratory Association and PCR lab HealthTrackRx, claims the FDA does not have the authority to scrutinize lab-developed tests. When the FDA finalized its test regulation plan last month, several experts said it was only a matter of time until someone in the lab industry sued.

Tests made in labs have historically gone unregulated by the FDA, as the agency considered them low-risk when it started regulating medical devices in 1976. But the tests have since become more numerous and complex, and the regulatory gray area enabled unreliable tests to thrive and harm patients. Infamous examples include Theranos’ blood tests, as well as misleading prenatal genetic tests from a range of companies.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Attacks on the drug industry will lead to fewer breakthroughs

focus

leisure time

WSS

Verily hires former Apple Health leader as chief scientific officer

Gilgo Beach: Police identify another victim in serial killing investigation

Trump drops motion seeking removal of DA probing efforts to overturn 2020 election in Georgia

It costs an awful lot of money to give away a kidney

2 officers injured in shooting in Orlando, police say

Heart disease in astronauts blamed on cosmic radiation

focus

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

hotspot

Hollywood unions extend contract negotiations for actors

For BCIs, commercial hurdles may be bigger than scientific ones

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Group behind ProMed defends move to subscription

Peter Hotez and the public health issue of online harassment

Medicare slashes safety net hospital payments by nearly $1 billion

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Verily hires former Apple Health leader as chief scientific officer

The high cost of giving birth even with insurance

Stem cell clinics for heart failure: buyer be wary

knowledge

Humana, CVS hope to turn members into patients at clinics

Treeline, Josh Bilenker's next biotech, is cloaked in mystery

OTC birth control: A brief history of over the counter pill design

What the cancer research community can learn from the Covid response

Florida officials tell state schools to teach AP Psychology 'in its entirety'

The a glaring gap in research on serious mental illness and primary care

entertainment

focus

leisure time

hotspot